NPA CEO Discusses Regulatory Status of Kratom
In this short video, former FDA official Daniel Fabricant, Ph.D., weighs in on kratom, the popular and controversial botanical.
At Natural Products Expo West, we asked the head of the Natural Products Association (NPA)—Daniel Fabricant, Ph.D.—about kratom, a popular and controversial botanical targeted in recent warning letters by his former employer, FDA. Hear what Fabricant had to say about regulatory issues surrounding kratom in the United States, including claims about its ability to help people addicted to opioids.
This is the second in a three-part video series based on a wide-ranging interview with Fabricant at Expo West, which was held in March in Anaheim, California.
About the Author(s)
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
You May Also Like